An Ontario-based biotechnology company and researchers from McMaster University have teamed up to develop a potential new method for delivering COVID-19 vaccines that would use an oral strip instead of a needle.
The thin strips, which would be infused with COVID-19 vaccine, would dissolve in the recipient’s mouth in approximately 11 seconds – much like a breath strip.
Mark Upsdell, the CEO of Rapid Dose Therapeutics (RDT), the biotechnology company developing the strips, explained that as the strip dissolves, the vaccine dose, or antigen, crosses through the blood-brain barrier and travels into the bloodstream.
To view the full story, please click here.
View more COVID-19 news as it pertains to the dental profession.
